Le Lézard
Classified in: Transportation, Science and technology
Subject: PLW

Clavister Applies for Patent on its Advanced Traffic Management Algorithm


STOCKHOLM, Oct. 18, 2017 /PRNewswire/ -- With a commitment to accelerated innovation, the company readies solutions for the market with intellectual protections.

Clavister (NASDAQ: CLAV), a leader in high-performance network security solutions, has submitted a patent to the Swedish Patent Agency concerning its newly innovated advanced traffic management algorithm, a solution invented by a team of senior software engineers at Clavister.

The solution primarily addresses quality of service (QoS) issues in congested networks, a critical challenge in multi-cored systems that need increase performance on every additional CPU core that is added to the system a.k.a scaling.

"Providing efficient Quality of Service (QoS) requires advanced algorithms and most of them suffer from scalability problems when the number of CPU cores in a system increases. The algorithm developed at Clavister can scale over a large number of CPU cores without losing accuracy. This means that Service Providers can more accurately provision services to their customers, which effectively improves customer satisfaction and ability to charge for services accordingly," states Mikael Olsson, CTO of Clavister.

For more information please contact:
Sam Coleman
Vice President of Marketing and Corporate Communications
+46(0)76-336-0116 
[email protected]

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/clavister/r/clavister-applies-for-patent-on-its-advanced-traffic-management-algorithm,c2369281

The following files are available for download:

http://mb.cision.com/Main/9441/2369281/737429.pdf

PDF


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Today, 2K announced TopSpin® 2K25, a revival of the beloved tennis simulation video game series developed by Hangar 13, is available now on PlayStation® 5 (PS5®), PlayStation®4 (PS4®), Xbox Series X|S, Xbox One, and PC via Steam. Featuring...

at 08:05
CPI Card Group Inc. ("CPI Card Group"), a payments technology company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and...

at 08:05
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:00
Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce its new two-year agreement with Canadian equestrian rider, Kassidy...



News published on and distributed by: